• 

  Biomaterials Market to Hit $540.5 Billion by 2032, Expands at 13.6% CAGR
• 

  Probiotics Market Set to Double to $131 Billion by 2032
• 

  Biosimilars Market to Hit $34.4 Billion by 2032
• 

  Orthobiologics Market On Path To USD 14.2 Billion
• 

  Proteomics Market On Course For USD 103.8 Billion Milestone By 2032
• 

  Antimicrobial Resistance Efforts to Improve Infection Control Practices